Situations Where Tirzepatide May Be Recommended Tirzepatide may be considered for patients who need stronger appetite control or who have struggled to achieve results with previous weight loss medications
Also, Prime Therapeutics released a study in October stating that findings indicate in the real world that individuals taking GLP-1 therapies without diabetes [over a two- year period] will see no medical cost offset. In other words, GLP-use did not lower other medical costs
The resulting supply shortages prompted the FDA to add semaglutide to its drug shortage list, and endocrinologists reported difficulty obtaining the medication for their type 2 diabetes patients who required it for glycemic control
"They're constantly updating their algorithm and offerings based on what they know about their community," says nutritionist Kristen Cassetty, RD
Our content is intended to be used and must be used for informational purposes only
As newer, more effective classes of GLP-1 drugs become available, older versions may also lose some of their pricing power
